Skip to content
Saturday, November 14, 2026
Tulip Advisor Agency

The Zimbabwean Government Turns Down ‘One-Sided’ US Health Aid Deal Because of Information Concerns

Medical aid image
The proposed American funding was aimed at initiatives for treating and preventing HIV/Aids, TB, and malaria.

Zimbabwe has turned down a significant US health deal worth $367m (272 million pounds) spanning five years due to the United States' insistence on confidential data.

This move came to light after a internal memorandum dated December was leaked, revealing that President Emmerson Mnangagwa deemed the agreement was "lopsided".

An official spokesman has since stated that the US was seeking genetic material for research and profit while was unwilling to guarantee the resulting advantages from any future treatments.

"We must now begin the difficult and regrettable task of winding down our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.

Her embassy noted the US had donated more than $1.9bn in health funding to Zimbabwe over the last two decades.

A physicians' group in Zimbabwe has called for more talks to find a deal agreeable to all parties so the country's vital HIV programme can proceed.

Broader Background

This development follows a comparable case in neighbouring Kenya, where a high court suspended a related deal with the US after legal challenges were raised about the safety of Kenyans' medical information.

After returning to office recently, US President Donald Trump has slashed foreign aid and closed the US Agency for International Development (USAID).

The agency had administered assistance for the US government, but Trump argued its expenditure was "wasteful" and his government was pursuing government-to-government deals to enhance transparency and responsibility.

Based on reports, 16 nations in Africa have so far agreed to these new health pacts, constituting over $18.3bn of fresh investment.

Specifics of the Declined Deal

The money for Zimbabwe would have supported "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"We are confident this collaboration could have provided extraordinary advantages for the people of Zimbabwe, especially the 1.2 million men, women and children presently receiving antiretroviral therapy via US-supported programmes," the Ambassador commented.

However, official spokesman Nick Mangwana argued the proposed deal was "unequal".

"Zimbabwe was being asked to share its biological resources and data for a long time, without any equivalent promise of access to any scientific breakthroughs – like new medicines or tests – that could result from that provided information," Mangwana explained.

"Effectively, our country would provide the basic resources for scientific discovery with no certainty that the final treatments would be available to our population if a new pandemic arise."

National Interest and Global Health

He also said that the US's withdrawal from the global health body and its push of one-on-one deals were undermining structures previously set up through the international health agency.

The spokesperson cited its Pathogen Access and Benefit Sharing scheme designed to manage future global health emergencies.

"This system is designed to ensure that when a country contributes its samples, the resulting advantages – such as vaccines and treatments – are shared equitably, not monopolised solely by those with the resources to create them."

These objections over the US deal "must not be interpreted as hostility towards the US," he added.

"We encourage further discussions with our American counterparts on how subsequent collaboration could be structured in a way that honours the sovereignty and dignity of both nations."

Medical Community Response

A leading public health body said it acknowledged the official position, but recommended that talks should continue considering much of the nation's Aids initiatives were funded by international support.

"If specific concerns arise, such as those involving information security or implementation frameworks, these can frequently be addressed through detailed discussion and mutually agreed protections," the group commented.

This impasse highlights the complex tensions between accepting much-needed international aid and safeguarding a country's data in an increasingly interconnected world.

About the author

Amber Nunez

Lena is a horticulturist and tulip specialist with over 15 years of experience in Dutch flower fields.

Tulip Advisor Agency

Type to search articles.